Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenna Shaw

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Reply to M.P. Decatris et alFunda Meric-Bernstam, Kenna Shaw, John Mendelsohn, et al.
Archives of Pathology & Laboratory Medicine|December 22, 2017
Ex Vivo Confocal Fluorescence Microscopy for Rapid Evaluation of Tissues in Surgical Pathology PracticeSavitri Krishnamurthy, Andrea Cortes, Mirtha Lopez, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2018
Confocal Fluorescence Microscopy Platform Suitable for Rapid Evaluation of Small Fragments of Tissue in Surgical Pathology PracticeSavitri Krishnamurthy, Kechen Ban, Kenna Shaw, et al.
JCO Clinical Cancer Informatics|January 6, 2022
Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in CancerJia Zeng, Christian X Cruz-Pico, Turçin Saridogan, et al.
Molecular Cancer Research : MCR|August 9, 2017
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal CanalVan Morris, Xiayu Rao, Curtis Pickering, et al.
Oncotarget|October 1, 2013
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancersShruti Desai, Minming Ding, Bin Wang, et al.
NPJ Precision Oncology|December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibitionNiamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Plos One|May 9, 2018
Cancer driver mutation prediction through Bayesian integration of multi-omic dataZixing Wang, Kwok-Shing Ng, Tenghui Chen, et al.
JCO Clinical Cancer Informatics|April 30, 2025
Data Events Are Safety Events: High-Reliability Organization Approach to Improving Data Quality and SafetyKelly Merriman, Emily Yu, Andrea Hawkins-Daarud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue SarcomaVivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Reply to M.P. Decatris et alFunda Meric-Bernstam, Kenna Shaw, John Mendelsohn, et al.
Archives of Pathology & Laboratory Medicine|December 22, 2017
Ex Vivo Confocal Fluorescence Microscopy for Rapid Evaluation of Tissues in Surgical Pathology PracticeSavitri Krishnamurthy, Andrea Cortes, Mirtha Lopez, et al.
Archives of Pathology & Laboratory Medicine|October 31, 2018
Confocal Fluorescence Microscopy Platform Suitable for Rapid Evaluation of Small Fragments of Tissue in Surgical Pathology PracticeSavitri Krishnamurthy, Kechen Ban, Kenna Shaw, et al.
JCO Clinical Cancer Informatics|January 6, 2022
Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in CancerJia Zeng, Christian X Cruz-Pico, Turçin Saridogan, et al.
Molecular Cancer Research : MCR|August 9, 2017
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal CanalVan Morris, Xiayu Rao, Curtis Pickering, et al.
Oncotarget|October 1, 2013
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancersShruti Desai, Minming Ding, Bin Wang, et al.
NPJ Precision Oncology|December 2, 2021
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibitionNiamh Coleman, Vivek Subbiah, Shubham Pant, et al.
Plos One|May 9, 2018
Cancer driver mutation prediction through Bayesian integration of multi-omic dataZixing Wang, Kwok-Shing Ng, Tenghui Chen, et al.
JCO Clinical Cancer Informatics|April 30, 2025
Data Events Are Safety Events: High-Reliability Organization Approach to Improving Data Quality and SafetyKelly Merriman, Emily Yu, Andrea Hawkins-Daarud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2017
Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue SarcomaVivek Subbiah, Christian Meyer, Ralph Zinner, et al.
Pageof 3